These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2961895)

  • 1. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
    Arevalo JA; Washington AE
    JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necessity for routine obstetric screening for hepatitis B surface antigen.
    Greenspoon JS; Martin J; Greenspoon RL; McNamara BT
    J Reprod Med; 1989 Sep; 34(9):655-8. PubMed ID: 2530344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
    Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB
    Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of antenatal hepatitis B screening and vaccination of infants.
    Thomas IL
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):331-5. PubMed ID: 2150586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.
    Okun NB; Larke RP; Waters JR; Joffres MR
    CMAJ; 1990 Dec; 143(12):1317-21. PubMed ID: 2147576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B: update on perinatal management. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1986 Apr; 134(8):883-6. PubMed ID: 3955481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all pregnant women be screened for hepatitis B surface antigen?
    Pesce AF; Crewe EB; Cunningham AL
    Med J Aust; 1989 Jan; 150(1):19-21. PubMed ID: 2491902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal hepatitis B virus infection: screening of pregnant women and protection of the infant.
    Stevens CE
    Ann Intern Med; 1987 Sep; 107(3):412-3. PubMed ID: 2956915
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine prenatal screening of Indian women for HBsAg: benefits derived versus cost.
    Sriprakash I; Anil TP
    Trop Doct; 1997 Jul; 27(3):176-7. PubMed ID: 9227020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should pregnant urban south African women be screened for hepatitis B?
    Guidozzi F; Schoub BD; Johnson S; Song E
    S Afr Med J; 1993 Feb; 83(2):103-5. PubMed ID: 8451683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec.
    Audet AM; Delage G; Remis RS
    Can J Public Health; 1991; 82(3):191-5. PubMed ID: 1909210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal-neonatal transmission of hepatitis B virus. Epidemiology and prevention.
    Zanetti AR
    Ann Ist Super Sanita; 1987; 24(2):277-84. PubMed ID: 2969205
    [No Abstract]   [Full Text] [Related]  

  • 15. Routine prenatal screening for hepatitis B surface antigen.
    Kane MA; Hadler SC; Margolis HS; Maynard JE
    JAMA; 1988 Jan; 259(3):408-9. PubMed ID: 3336167
    [No Abstract]   [Full Text] [Related]  

  • 16. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
    JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunization of infants at risk.
    Gilbert GL
    Med J Aust; 1984 Aug; 141(4):213-6. PubMed ID: 6482756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jun; 37(22):341-6, 351. PubMed ID: 2967425
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of hepatitis B virus infection in pregnant women in the Montreal area.
    Delage G; Montplaisir S; Rémy-Prince S; Pierri E
    CMAJ; 1986 Apr; 134(8):897-901. PubMed ID: 3955483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.